So I will be looking for us to use the fewest questionnaires required for the GWAS to be successful but with the above action we will be making it easier for anybody who wishes to follow-on with any future study, whether that be questionnaire based or not.
Thank you Andy. Perhaps I'm just being over-anxious about this, but is the association that the GWAS will be looking for against the genes: 'having ME vs not having ME'?
Or will it go as far as sub-phenotyping ME cases?
One big reason I suggested additional questionnaires was because ME is heterogeneous, there is a chance that it is not one genotype but several different ones, each comprised of a different cluster of SNPs?
And that lumping them all together in one 'having ME vs not having ME' phenotype analysis might not turn up (or might dilute) any statistical significance?
If this were to be the case, it might be necessary to sub-phenotype the ME cases to see whether there was statistical significance in clusters of SNPs associated with sub-phenotypes?
The only practical way to sub-phenotype ME cases on this scale, with the resources available to the GWAS, would be by questionnaires to identify symptom clusters, disease/health history, onset type, environmental exposures, etc.
I am basing this concern on the oft-cited concept that ME might not be one homogeneous disease with one genotype, but might be several different diseases with very similar presentations. In my mind it would be valuable to have data that can be used to try to sub-phenotype ME cases to see whether this turns out more statistically significant results, in case the whole-cohort 'having ME vs not having ME' doesn't identify statistically significant associations.
Because in the latter scenario it would be a lot of work for nothing, whereas if there was data to draw on to try sub-typing patients this could increase the likelihood of getting meaningful results, especially since we know ME is complex and heterogeneous.
Does this make sense?